Current Cancer Drug Targets


Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 8 Issue: 8, December

mTOR Pathway and mTOR Inhibitors as Agents for Cancer Therapy

Volume:8   Issue: 8
Pp: 647-665
Paolo Baldo, Sara Cecco, Elisa Giacomin, Renzo Lazzarini, Barbara Ros and Stefano Marastoni
DOI: 10.2174/156800908786733513
Published on: 01 March, 2012

Anticancer Immunotherapy in Combination with Proapoptotic Therapy

Volume:8   Issue: 8
Pp: 666-675
Oystein Bruserud, Elisabeth Ersvaer, Astrid Olsnes and Bjorn Tore Gjertsen
DOI: 10.2174/156800908786733496
Published on: 01 March, 2012

Anti-Angiogenic Targets in the Treatment of Advanced Renal Cell Carcinoma

Volume:8   Issue: 8
Pp: 676-682
Daniel Y.C. Heng and Ronald M. Bukowski
DOI: 10.2174/156800908786733450
Published on: 01 March, 2012

PEDF as an Emerging Therapeutic Candidate for Osteosarcoma

Volume:8   Issue: 8
Pp: 683-690
Crispin R. Dass, Eugene T.H. Ek and Peter F.M. Choong
DOI: 10.2174/156800908786733487
Published on: 01 March, 2012

Melatonin as a Selective Estrogen Enzyme Modulator

Volume:8   Issue: 8
Pp: 691-702
S. Cos, A. Gonzalez, C. Martinez-Campa, M. D. Mediavilla, C. Alonso-Gonzalez and E. J. Sanchez-Barcelo
DOI: 10.2174/156800908786733469
Published on: 01 March, 2012

Budesonide and Phenethyl Isothiocyanate Attenuate DNA Damage in Bronchoalveolar Lavage Cells of Mice Exposed to Environmental Cigarette Smoke

Volume:8   Issue: 8
Pp: 703-708
Rosanna T. Micale, Francesco D'Agostini, Vernon E. Steele, Sebastiano La Maestra and Silvio De Flora
DOI: 10.2174/156800908786733423
Published on: 01 March, 2012

Choline Kinase Alpha Depletion Selectively Kills Tumoral Cells

Volume:8   Issue: 8
Pp: 709-719
Monica Banez-Coronel, Ana Ramirez de Molina, Agustin Rodriguez-Gonzalez, Jacinto Sarmentero, Mª Angeles Ramos, Miguel Angel Garcia-Cabezas, Lourdes Garcia-Oroz and Juan Carlos Lacal
DOI: 10.2174/156800908786733432
Published on: 01 March, 2012

ADAM Proteins- Therapeutic Potential in Cancer

Volume:8   Issue: 8
Pp: 720-732
Xinjie Lu, Dong Lu, Mike Scully and Vijay Kakkar
DOI: 10.2174/156800908786733478
Published on: 01 March, 2012

The PIK3CA Gene as a Mutated Target for Cancer Therapy

Volume:8   Issue: 8
Pp: 733-740
John P. Gustin, David P. Cosgrove and Ben Ho Park
DOI: 10.2174/156800908786733504
Published on: 01 March, 2012

Cell Cycle Regulatory Protein 5 (Cdk5) is a Novel Downstream Target of ERK in Carboplatin Induced Death of Breast Cancer Cells (Supplementary Data)

Volume:8   Issue: 8
Pp: 741-752
Ankur Kumar Upadhyay, Amrendra Kumar Ajay, Sandeep Singh and Manoj Kumar Bhat
DOI: 10.2174/156800908786733405
Published on: 01 March, 2012

Protective Effect of NSAIDs on Cancer and Influence of COX-2 C G Genotype

Volume:8   Issue: 8
Pp: 753-764
C. Siemes, L. E. Visser, J. W.W. Coebergh, A. Hofman, A. G. Uitterlinden and B.H. Ch. Stricker
DOI: 10.2174/156800908786733414
Published on: 01 March, 2012


Volume:8   Issue: 8
Pp: 765-765

DOI: 10.2174/156800908786733441
Published on: 01 March, 2012